Strengthened Aged Care Quality Standards: What Action 5.5.3 Asks of Continence Care
By Kim Hando
, Owner & Founder
│ 02 September 2026
Last reviewed: 02 September 2026
Share
An assessor asks how your home manages continence. Under the previous Quality Standards you would have reached for the personal care standard and made the case from there. Since 1 November 2025 there is a specific place to point, with a number on it, and knowing the number is the difference between answering the question and building the answer on the spot.
Continence now sits inside Standard 5, Clinical care, in the strengthened Aged Care Quality Standards. That is the substantive change. Continence care is no longer read out of a general personal care duty; it is named as a high impact and high prevalence clinical risk.
The procurement side of this, supplier evaluation, trials and how homes buy, is covered in our guide for Australian providers. This article stays on the standard itself, and on what a home has to be able to show.
What the strengthened Aged Care Quality Standards say about continence
The strengthened Aged Care Quality Standards commenced on 1 November 2025 with the Aged Care Act 2024. The Aged Care Quality and Safety Commission records that the previous Quality Standards were in effect between 1 July 2019 and 31 October 2025. Under the strengthened Standards, continence sits under Standard 5: Clinical care, within Outcome 5.5, and carries its own named action, Action 5.5.3 Continence.
Standard 5 applies to providers registered in Category 5, nursing and transition care, and Category 6, residential care including respite. Providers registered in Category 4 must meet Outcome 5.1 where they deliver care management or restorative care management services. The Commission states this on its own Standard 5 page, and it is the first thing worth checking, because the standard's reach follows registration category rather than service label.
The reclassification is worth pausing on, because it changes the kind of evidence that answers the question. A personal care obligation is evidenced by what staff did. A clinical risk obligation is evidenced by what the home identified, monitored and managed, which is a documentary trail rather than a task list.
Continence moved from the first kind to the second on 1 November 2025. Continence documentation written before that date was written to answer a different question.
Outcome 5.5 and Action 5.5.3: two layers, and the difference matters
This is where second-hand summaries go wrong, so it is worth setting out carefully.
The legally binding text sits in the Aged Care Rules 2025. Section 15-30 sets out Standard 5 as a series of Outcomes with numbered subsections. Outcome 5.5 is titled Safety of clinical care services, and it reads: "The provider must identify, monitor and manage high impact and high prevalence risks in the delivery of clinical care services: (a) to ensure the delivery of safe and quality clinical care services; and (b) to reduce the risk of harm to individuals." The Rules do not use Action numbering, and the word continence does not appear anywhere in Outcome 5.5.
The Actions sit one layer down, in the Commission's own framework. The Commission's Strengthened Quality Standards framework analysis, published 19 May 2026 and based on the final strengthened Quality Standards published in August 2025, sets out the structure in its own words. Each strengthened Quality Standard includes an intent, an expectation statement, Outcomes, described as "what we assess providers against", and Actions, described as "what providers can do to meet the outcomes".
So the Outcome is the assessable obligation and the Action is the Commission's articulation of what meeting it looks like. Neither replaces the other. If you are drafting policy, cite the Outcome. If you are building a workflow, work to the Action.
Action 5.5.3, Continence
"The provider implements processes for continence care by:
- a. optimising the individual's dignity, comfort, function and mobility
- b. ensuring safe and responsive assistance with toileting
- c. managing incontinence
- d. protecting the individual's skin integrity and minimising incontinence associated dermatitis."
Source: Aged Care Quality and Safety Commission, Strengthened Quality Standards framework analysis, Standard 5: Clinical care, published 19 May 2026.
Worth noting alongside it: Action 5.5.1 asks the provider to implement "a system that supports the identification, monitoring and management of high impact and high prevalence clinical care risks, including but not limited to Actions 5.5.2 to 5.5.10". The hedge is the Commission's own. The named actions are a floor, not a closed list, so a risk your own home sees that is not on the list still belongs in the system.
Outcome 5.5 covers a range of clinical risks beyond continence, each with its own action. This article stays with the continence one.
Action 5.5.3, limb by limb
Four limbs, four different things to run and evidence. The fourth is deliberately left where it belongs.
| Limb of Action 5.5.3 | What it asks for | What it looks like in the home | The record that shows it |
|---|---|---|---|
| a. Optimising dignity, comfort, function and mobility | Continence care that supports the person's independence and self-image, not just containment | Product type chosen against mobility and self-toileting ability, changes done privately, no product that restricts movement more than the person's need requires | Care plan entry naming product type and the mobility rationale behind it |
| b. Safe and responsive assistance with toileting | Toileting help that arrives when the person needs it and is delivered safely | Call bell response, continence-aware toileting routines, transfer and mobility aids where they are needed | Response records, toileting routines in the care plan, incident reporting where a response failed |
| c. Managing incontinence | The active clinical management of the condition itself, not just the products | Assessment of type and pattern, referral where the cause may be treatable, product matched to assessed need, review when things change | Assessment record, referral record, product and size recorded against assessed need, review date |
| d. Protecting skin integrity and minimising incontinence associated dermatitis | Out of scope for this article | Route any skin concern to a continence nurse or the resident's GP | Handled through your clinical referral pathway, not through this article |
Limb (d) is quoted here because a partial quotation of a regulation is worse than a complete one. It is a skin integrity matter, it belongs with a clinician, and this article stops at the referral.
Where the assessment obligation actually lives
Action 5.5.3 asks the provider to manage incontinence. It does not itself spell out an assessment. That obligation sits elsewhere in the Standards, and knowing where saves argument in an audit.
| The obligation | Where it sits | What the Rules or the Action say |
|---|---|---|
| An individualised care and services plan, developed with the person and reviewed | Outcome 3.1, Standard 3, Aged Care Rules 2025 s 15-20 | Plans must describe the person's current care needs, goals and preferences, include strategies for risk management and preventative care, and be regularly reviewed and used by workers to guide delivery |
| Clinical assessment, planning, management and review | Outcome 5.4, Standard 5, s 15-30(9) | Clinical care must encompass "clinical assessment, prevention, planning, treatment, management and review to minimise harm and optimise quality of life, reablement and maintenance of function" |
| Early response when needs change | Outcome 5.4, s 15-30(11) | "The provider must support early identification of, and response to, changing clinical needs" |
| A system for high impact and high prevalence clinical risks | Action 5.5.1, under Outcome 5.5 | A system supporting identification, monitoring and management of those risks, "including but not limited to Actions 5.5.2 to 5.5.10" |
| Workers competent to do it | Action 5.1.3, under Outcome 5.1 | Processes to ensure aged care workers providing clinical care services are "qualified, competent and work within their defined scope of practice or role" |
| Choice and dignity in how it is delivered | Outcomes 1.2 and 1.3, Standard 1, s 15-10 | Care delivered in a way that treats people with dignity and respect and respects personal privacy, with support to exercise choice and make decisions |
Put together, that is the shape of a defensible continence assessment: person-centred, conducted by someone working within their scope, written into the care and services plan alongside the goals and preferences the person actually expressed, and reviewed rather than set once on admission.
Two practical consequences follow. The first is that an assessment done once, at admission, does not answer either Outcome 3.1 or Outcome 5.4, because both are written in terms of review and of response to change. The second is that the assessment has to be legible to somebody who was not there. A care plan entry recording a product and a size, with no assessed need written beside it, reads to an assessor as a stock decision rather than a clinical one, whether or not the product happens to be the right one.
Who conducts it is a scope-of-practice question for your own clinical governance framework rather than something the Standards prescribe by role. Where a resident's continence is complex, or where the cause may be treatable rather than simply managed, a continence nurse is the right referral. Our guide to finding and working with a continence nurse covers how that referral works in Australia. The National Continence Helpline, funded by the Australian Government and staffed by nurse continence specialists, is on 1800 33 00 66, and Continence Health Australia is the national body for clinical continence information.
This article describes the obligation. It is not a clinical assessment protocol, and it should not be used as one.
Product matched to assessed need, and the record that shows it
Here is the part that turns a policy into an audit answer. Limb (c) asks for incontinence to be managed. Managing it means the product a resident wears has to follow their assessed need, and the home has to be able to show the link between the two.
In practice that means holding a range rather than a default. A resident who is ambulant and manages their own toileting is in a different product from a resident who needs a carer to change them lying down. Pull-up pants suit the first. Slips suit the second.
Our pull-ups run across four sizes covering waist measurements from 60cm to 180cm, and the slips run across four sizes over the same waist span, with different absorbency at each size. Sizing is by waist measurement, and a resident's size in one product type does not carry across to the other.
Daytime and overnight are different problems. An insert booster pad added inside a primary garment extends capacity overnight without moving the resident into a bulkier product, which matters for comfort and for limb (a). Bed and chair protection is a separate decision again, and the three products are separate listings: Underpads Small for chair and targeted use, Underpads Regular for broader bed protection, and the Maxi Bed Mat for overnight bed protection.
We are not going to reproduce the selection guidance here, because it already exists and it is written for the people who do it. How to measure for continence products covers the waist measurement method. What absorbency levels actually mean covers the bands. What to look for in heavier-need products covers the top of the range.
The compliance point sits one step past that. It is not enough for the right product to be on the resident. The care plan has to show why that product, in that size, for that person, and when the choice is next being looked at. A store room stocked in one or two sizes cannot produce that record for every resident, because the record would not be true.
Where shelving holds one or two sizes while the residents in the building need a wider spread, staff are left making the fit work rather than choosing it.
Funding questions sit outside the Standards. Who pays for continence products in aged care covers where the responsibility falls, and residents with an NDIS plan should be directed to their plan manager or ndis.gov.au for what their own plan funds.
Dignity, choice and single-brand supply
Limb (a) puts dignity, comfort, function and mobility inside the clinical action itself, and Standard 1 carries choice and dignity as obligations in their own right. Read together with an individualised assessment duty, they raise an obvious question about a supply arrangement that offers one manufacturer's product to every resident in the building.
The question is not whether single-brand supply is prohibited. It is whether a home on a single-brand arrangement can produce, resident by resident, a record showing the product follows an assessed need and reflects a preference the person was actually asked about. Our supplier evaluation, trials and procurement guide works through what that means for how you buy. This article defers to it rather than repeating it.
There is a version of this that is not about brands at all. A home can hold several brands and still fail the question, if the range it holds does not span the sizes and absorbencies its residents assess into. A home on a narrower arrangement can pass it, if it can show that arrangement was chosen against resident need and is looked at again when that need changes. The evidence turns on fit to assessed need, not on the number of names on the shelf.
What an assessor is looking for
Four things, and they are all documentary. None of them is a new artefact. Each is something a home is already producing for other purposes. The question is whether continence is actually represented in them.
- Assessment records. Evidence that each resident's continence was assessed as an individual, by someone working within their scope, rather than assigned a product on admission.
- Care and services plans. The assessed need, the product type and size selected, the rationale, and the person's own goals and preferences, in the plan the staff actually work from.
- Product trial and change records. Where a product was changed, what prompted it, what was trialled, and what the outcome was.
- Review cadence. A next review date, met. Outcome 3.1 asks for plans to be regularly reviewed, and Outcome 5.4 asks for early identification of changing needs. A plan reviewed only at the annual cycle answers neither.
If your continence documentation already carries those four, Action 5.5.3 is a naming exercise for you. If it carries the product but not the reasoning, that is the gap worth closing first. It is also a cheap gap to close, because the reasoning already exists in the heads of the staff who made the decision. It just has not been written down where an assessor can read it.
Where Comfort First fits
Comfort First is Australian owned and run, and supplies residential aged care homes with a continence range across absorbencies and waist sizes, including pull-ups, slips, booster pads and bed protection. We support product trials so a product can be matched to a resident's assessed need rather than to what happens to be in the store room.
Browse the full Comfort First range, or arrange a product trial for your home. If you would rather talk it through, call 03 5443 2239 or email sales@comfortfirst.au.